Fulcrum approves retention bonuses for CEO, CLO, CFO; accounting officer departs after restructuring

Fulcrum Therapeutics, Inc.

CEO Alex Sapir receives $370,040 retention bonus; CLO Curtis Oltmans $195,480; CFO Alan Musso $195,200.
Bonuses payable on change in control or termination without cause after fulfilling transitional duties.
VP+ level employees added to change-in-control severance if terminated within 6 months before a CIC.
VP Finance & principal accounting officer Greg Tourangeau departs mutually; no disagreement on financial matters.
Restructuring follows discontinuation of pociredir for sickle cell disease, previously disclosed May 31, 2026.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Greg Tourangeau

Vice President, Finance and principal accounting officer

FULC · Fulcrum Therapeutics, Inc.

Filed: June 11, 2026, 4:30 PM ET

On June 10, 2026, Fulcrum and Greg Tourangeau, Fulcrum’s Vice President, Finance and principal accounting officer, mutually agreed that Mr. Tourangeau will depart from his position at Fulcrum on a date to be agreed between Mr. Tourangeau and Fulcrum.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Greg Tourangeau departed as Vice President, Finance and principal accounting officer at Fulcrum Therapeutics, Inc..

Action: departed
Role: Vice President, Finance and principal accounting officer

Exact text from the filing

On June 10, 2026, Fulcrum and Greg Tourangeau, Fulcrum’s Vice President, Finance and principal accounting officer, mutually agreed that Mr. Tourangeau will depart from his position at Fulcrum on a date to be agreed between Mr. Tourangeau and Fulcrum.

View on SEC.gov

Fulcrum Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-267659

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.